When obstructive sleep apnea is discussed in clinical settings, the emphasis is typically on daytime sleepiness. But the cardiovascular consequences of untreated OSA are at least as significant and in many respects more clinically urgent. Repeated cycles of oxygen desaturation, sympathetic nervous system activation, and intrathoracic pressure swings produce vascular injury through mechanisms that are now well understood.

The Three Primary Mechanisms

  • Intermittent hypoxia: repeated drops in oxygen saturation activate the hypoxia-inducible factor pathway, promote oxidative stress, and drive vascular inflammation
  • Sympathetic nervous system activation: each arousal from apnea triggers a catecholamine surge, causing heart rate acceleration and blood pressure spike; nightly repetition chronically elevates basal sympathetic tone and promotes arterial stiffness
  • Negative intrathoracic pressure: each obstructed respiratory effort generates large negative pressures that mechanically stress the pericardium and cardiac chambers, contributing to left ventricular remodelling over time

Hypertension

The most robust cardiovascular consequence of OSA is hypertension. The Wisconsin Sleep Cohort Study found a dose-response relationship between AHI and hypertension risk: adults with AHI above 15 had 2.89 times the odds of hypertension compared to those without OSA, after adjustment for obesity, age, and sex. OSA is now considered the most common secondary cause of hypertension in adults over 40, and should be evaluated in any hypertensive patient who also snores, reports daytime sleepiness, or has a resistant hypertension pattern.

Atrial Fibrillation

OSA is associated with a 2 to 4-fold increased risk of atrial fibrillation. Sustained CPAP treatment reduces AF recurrence after cardioversion by approximately 50% (Kanagala et al., 2003, Circulation). The proposed mechanism involves hypoxia-driven atrial remodelling and altered pulmonary vein firing patterns. Cardiologists now routinely ask about sleep symptoms when managing AF.

Stroke

OSA has been identified as an independent stroke risk factor in multiple prospective studies. A 2010 New England Journal of Medicine paper by Yaggi et al. found that severe OSA was associated with a hazard ratio of 3.3 for stroke or death, independent of other cardiovascular risk factors. The risk reduction with CPAP treatment is substantial but requires consistent use (above 4 hours per night) for full benefit.

Sources

  • Peppard PE, et al. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine, 342(19), 1378-1384.
  • Kanagala R, et al. (2003). Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation, 107(20), 2589-2594.
  • Yaggi HK, et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine, 353(19), 2034-2041.

Share this article

LinkedInFacebookWhatsApp